Rosemarie de la Cruz Bernabe

Bilde av Rosemarie de la Cruz Bernabe
English version of this page
Telefon +47-22850624
Brukernavn
Besøksadresse Kirkeveien 166 Fredrik Holsts hus 0450 OSLO
Postadresse Postboks 1130 Blindern 0318 OSLO

Publikasjoner

  • Bernabe, Rosemarie de la Cruz (2016). What do international ethics guidelines say in terms of the scope of medical research ethics?. BMC Medical Ethics.  ISSN 1472-6939.
  • Bernabe, Rosemarie de la Cruz (2014). Fiduciary obligation of physician-researchers in phase IV clinical trials. BMC Medical Ethics.  ISSN 1472-6939.
  • Bernabe, Rosemarie de la Cruz (2014). Patient representatives’ contributions to the benefit-risk assessment task of EMA scientific committees. British Journal of Clinical Pharmacology.  ISSN 0306-5251.
  • Bernabe, Rosemarie de la Cruz (2013). Phase IV non-inferiority trials and additional claims of benefit. BMC Medical Research Methodology.  ISSN 1471-2288.
  • Bernabe, Rosemarie de la Cruz (2012). Decision theory and the evaluation of risks and benefits of clinical trials. Drug Discovery Today.  ISSN 1359-6446.
  • Bernabe, Rosemarie de la Cruz (2012). The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methods. BMC Medical Ethics.  ISSN 1472-6939.

Se alle arbeider i Cristin

  • Bernabe, Rosemarie de la Cruz (2017). Exportation of unethical practices to low and middle income countries in biomedical research. Revista de Bioética y Derecho: Perspectivas Bioéticas.  ISSN 1886-5887.
  • Bernabe, Rosemarie de la Cruz (2017). The ambivalent place of ethics in European regulatory documents. Drug Discovery Today.  ISSN 1359-6446.
  • Bernabe, Rosemarie de la Cruz (2016). Drug regulators and ethics: which GCP issues are also ethical issues?. Drug Discovery Today.  ISSN 1359-6446.
  • Bernabe, Rosemarie de la Cruz (2012). Consent in psychiatric biobanks for pharmacogenetic research. International Journal of Neuropsychopharmacology.  ISSN 1461-1457.
  • Bernabe, Rosemarie de la Cruz (2011). Informed consent and phase IV noninterventional drug research. Current Medical Research and Opinion.  ISSN 0300-7995.
  • Bernabe, Rosemarie de la Cruz (2011). Is informed consent necessary for randomized phase IV “observational” drug studies?. Drug Discovery Today.  ISSN 1359-6446.
  • Bernabe, Rosemarie de la Cruz (2009). The need to explicate the ethical evaluation tools to avoid ethical inflation. American Journal of Bioethics.  ISSN 1526-5161.

Se alle arbeider i Cristin

Publisert 6. apr. 2017 15:10 - Sist endret 7. apr. 2017 12:06